Toshiki Kamata

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Clinical Significance of Molar Count in Esophageal Squamous Cell Carcinoma: Propensity Score Matching Study.

Clinical Significance of Molar Count in Esophageal Squamous Cell Carcinoma: Propensity Score Matching Study.

Journal: Anticancer research

Published: July 07, 2025

A Case of Pseudo Progression during SOX+Nivolumab Therapy for Unresectable Gastric Cancer

A Case of Pseudo Progression during SOX+Nivolumab Therapy for Unresectable Gastric Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 14, 2025

Exosome-Derived miR-148a-3p Protect against Tumor Proliferation and Metastasis of Esophageal Squamous Carcinoma.

Exosome-Derived miR-148a-3p Protect against Tumor Proliferation and Metastasis of Esophageal Squamous Carcinoma.

Journal: Oncology

Published: December 04, 2024

High Expression of Tetraspanin CD63 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.

High Expression of Tetraspanin CD63 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Journal: Oncology

Published: November 04, 2024

Circulating exosome-derived miR-191-5p is a novel therapeutic biomarker for radiotherapy in esophageal squamous cell carcinoma patients.

Circulating exosome-derived miR-191-5p is a novel therapeutic biomarker for radiotherapy in esophageal squamous cell carcinoma patients.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: October 01, 2024

Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma.

Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma.

Journal: Cancer diagnosis & prognosis

Published: August 15, 2024

A Case of Advanced Gastric Cancer Treated with Conversion Surgery followed by Nivolumab Combination Chemotherapy

A Case of Advanced Gastric Cancer Treated with Conversion Surgery followed by Nivolumab Combination Chemotherapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: April 21, 2024

Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.

Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.

Journal: Oncology

Published: December 11, 2021

Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Journal: Oncology

Published: June 20, 2021

Tumor-derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines.

Tumor-derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines.

Journal: Cancer science

Published: April 16, 2020

Successful Treatment of Gastric Cancer with Conversion Surgery after Nivolumab Treatment-A Case Report

Successful Treatment of Gastric Cancer with Conversion Surgery after Nivolumab Treatment-A Case Report

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: October 22, 2019

Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test

Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: October 22, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026